Haemonetics | HAE - Cash And Equivalent


Haemonetics reported $223.38M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Baxter International USD 2.15B 133M Jun/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Boston Scientific USD 539M 914M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Cooper Companies USD 138.8M 13.9M Mar/2026
Fresenius EUR 2.06B 752M Mar/2026
Fresenius Medical Care EUR 1.06B 177.89M Jun/2026
Globus Medical USD 507.74M 53.2M Jun/2026
Haemonetics USD 223.38M 22.06M Jun/2026
ICU Medical USD 288.33M 19.63M Mar/2026
Intuitive Surgical USD 8.63B 646.3M Jun/2026
Medtronic USD 1.69B 258M Jun/2026
Merit Medical Systems USD 448.7M 39.38M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Quidel USD 123.4M 17M Jun/2026
ResMed USD 1.47B 191.28M Jun/2026
STAAR Surgical USD 148.58M 16.72M Jun/2026
Steris USD 482.3M 42.7M Jun/2026
Stryker USD 3.39B 513M Jun/2026
Teleflex USD 300.16M 9.25M Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
US Physical Therapy USD 24.89M 3.55M Jun/2026
Zimmer Biomet Holdings USD 410M 14.2M Jun/2026